WED 237 Phosphorodiamidate morpholino oligomers for treatment of duchenne muscular dystrophy | Journal of Neurology, Neurosurgery & Psychiatry

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

JNNP 100

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

Association of British Neurologists 2018 Meeting Abstracts

Poster session

WED 237 Phosphorodiamidate morpholino oligomers for treatment of duchenne muscular dystrophy

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Kate M, May T, Michela G, et al

WED 237 Phosphorodiamidate morpholino oligomers for treatment of duchenne muscular dystrophy

Journal of Neurology, Neurosurgery & Psychiatry 2018;89:A34.